Results 171 to 180 of about 9,804 (228)

Clinical Evaluation of Potential Interaction Between Bemnifosbuvir and Ruzasvir With an Assessment of Food Effect: Results of a Phase 1 Study in Healthy Participants. [PDF]

Clin Pharmacol Drug Dev
Zhou XJ, Morelli G, Montrond M, Lynch S, Pietropaolo K, Belanger B, Horga A, Hammond J.   +7 more
europepmc   +1 more source

Retreatment of patients with chronic hepatitis C, subtype 3a, and cirrhosis, who previously failed a regimen containing second-generation NS5A inhibitors with sofosbuvir + glecaprevir/pibrentasvir and ribavirin for 16-24 weeks. [PDF]

J Virol
Fedorchenko SV, Klimenko Z, Martynovich T, Solianyk I, Suprunenko T.   +4 more
europepmc   +1 more source

Resistance analysis and characterization of a thiazole analogue, BP008, as a potent hepatitis C virus NS5A inhibitor. [PDF]

Antimicrob Agents Chemother, 2012
Lin HM, Wang JC, Hu HS, Wu PS, Yang CC, Wu CP, Pu SY, Hsu TA, Jiaang WT, Chao YS, Chern JH, Yeh TK, Yueh A.   +12 more
europepmc   +1 more source

Structural bioinformatics approaches for predicting novel drug targets in hepatitis C virus proteins: a comprehensive analysis. [PDF]

Sci Rep
Qu M, Gao M, Sang X, Yu M, Guan Z, Chang W.   +5 more
europepmc   +1 more source

Development of a Norway Rat Hepacivirus Reporter for High-Throughput Quantification of Neutralising Antibodies

Kennedy MJ, Wolfisberg R, Thorselius CE, Collignon L, Lundsgaard EA, Nielsen L, Holmbeck K, Bukh J, Scheel TKH.   +8 more
europepmc   +1 more source

2025 KASL clinical practice guidelines for management of hepatitis C. [PDF]

Clin Mol Hepatol
Jang ES, Heo NY, Jeong JY, Park JG, Song DS, Cho EJ, Lee CH, Lee JS, Yoon JH, Han SK, Jung YK, Korean Association for the Study of the Liver (KASL).   +11 more
europepmc   +1 more source

A key role for hepatitis C virus NS5A serine 225 phosphorylation revealed by super-resolution microscopy. [PDF]

Sci Rep
Goonawardane N, Yin C, Roberts GC, Zothner C, Harris M.   +4 more
europepmc   +1 more source

Prevalence of Drug Resistance Associated Substitutions in Persons With Chronic Hepatitis C Infection and Virological Failure Following Initial or Re-treatment With Pan-genotypic Direct-Acting Antivirals: A Systematic Review and Meta-analysis. [PDF]

Clin Infect Dis
Inzaule S, Easterbrook P, Latona A, Ford NP, Irving W, Matthews PC, Vitoria M, Duncombe C, Giron A, McCluskey S, Lesi O, Tchamgoue S, Halford R, Adda D, Thomson E, Dusheiko G, Jordan MR.   +16 more
europepmc   +1 more source